The most prevalent and consistent dose-limiting side effects observed across studies of FGF21 analogs in patients with metabolic disease are gastrointestinal (GI), including mild-to-moderate nausea and diarrhea (183, 245, 246, 298, 301)
"The novel glucagonagonist component introduces lessunderstood longterm safety considerations, so it is imperative that patients are followed closely by healthcare professionals experienced with this class of medicines, with cautious, stepwise use, despite the impressive efficacy," he cautioned.
Seek emergency care immediately for signs of severe allergic reaction such as difficulty breathing, throat tightness, or rapid facial swelling
Frequently Asked Questions What are the most common electrolyte imbalances with GLP-1 medications
We will also discuss why the delivery method of a supplement is just as important as the ingredient itself
Let's understand this puzzle